TScan Therapeutics Inc
TCRX
NASDAQ
Biotechnology
$0.78
USD
+0.01 (+0.88%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $50.45M
Volume 277.3K
Price Target
$5.00 – $6.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $6.00 and a min estimate of $5.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$5.50
+$0.5 vs prior
Implied Upside
+605.1%
+64.1% vs prior
Analyst Covering
2
+1 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
67%
Most ratings are recent - from the last 3 months
Analyst Agreement
Moderate
Targets show moderate spread across analysts
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Gil Blum | Needham | Buy | Reiterated | 1 month ago | Plus | Plus | Plus |
David Nierengarten | Wedbush | Buy | Reiterated | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
